Save the Date!
APNA Clinical Psychopharmacology Institute West
March 16-17, 2020
Hilton San Diego Mission Valley
901 Camino Del Rio South
San Diego, CA 92108
Planned for Nurses, by Nurses.
CPI West brings the clinically relevant sessions from the APNA Annual Clinical Psychopharmacology Institute to the west coast! Experience two days of continuing nursing education in psychopharmacology, planned for nurses, by nurses. Earn up to 10 contact hours in pharmacology.
|Saturday, March 16|
11:00am - 5:30pm
12:00pm - 1:30pm
1:45pm – 3:15pm
3:30pm – 5:00pm
5:15pm – 5:45pm
5:45pm – 6:45pm
|Sunday, March 17|
7:30am - 4:00pm
8:00am – 9:30am
9:45am – 11:15am
11:45am – 1:15pm
1:30pm – 3:00pm
3:15pm – 3:45pm
*Originally presented at the APNA 16th Annual Clinical Psychopharmacology Institute June 2018 in Baltimore, Maryland. The sessions are being re-presented at CPI West for our nurses on the west coast.
Registration is now closed.
(Deadline: Tuesday, February 19)
(Deadline: Monday, March 11)
ONLINE: Hotel Reservations at the Hilton
Guest room reservations are made on a first-come, first served basis at $139 per night until the room block is sold out. It is recommended to make hotel reservations as early as possible. Room rates are subject to change without notice and are based on availability.
PHONE: Call the Hilton at 1-800-682-6099
Please reference group code "AP2" to the reservation agent and inform that you want to make a reservation at the Hilton San Diego Mission Valley.
The Hilton Mission Valley Parking Garage will provide a discounted rate to CPI West attendees.
Staying overnight: $13.00 per day ($20 valet)
Driving in each day: $10.00 per day
APNA CPI West Exclusive Sponsorship
The APNA Clinical Psychopharmacology Institute West is exclusively sponsored by Neurocrine Biosciences, Inc. While the conference has received this funding support, the content of all information presented and all activities associated with the conference are at the sole discretion of APNA an have been in no way influenced by Neurocrine Biosciences, Inc.